Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
SI-BONE Inc
SIBN
$684M
| $1.13M | ﹤0.01% |
47,500
| – | – |
|
2027
DNOW Inc
DNOW
$1.65B
| $1.13M | ﹤0.01% |
247,700
+3,900
| +2% | +$17.7K |
|
2028
First Foundation Inc
FFWM
$485M
| $1.12M | ﹤0.01% |
86,000
+1,300
| +2% | +$17K |
|
|
EXK
2029
Endeavour Silver
EXK
$1.71B
| $1.12M | ﹤0.01% |
321,000
| – | – |
|
|
EGRX
2030
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.12M | ﹤0.01% |
26,400
+500
| +2% | +$21.2K |
|
2031
Winmark
WINA
$1.71B
| $1.12M | ﹤0.01% |
6,500
| – | – |
|
|
SRG
2032
Seritage Growth Properties
SRG
$251M
| $1.12M | ﹤0.01% |
83,138
+3,300
| +4% | +$44.4K |
|
|
BMTC
2033
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.12M | ﹤0.01% |
44,900
| – | – |
|
2034
Enova International
ENVA
$2.91B
| $1.12M | ﹤0.01% |
68,100
-5,500
| -7% | -$90.1K |
|
2035
Groupon
GRPN
$918M
| $1.12M | ﹤0.01% |
54,678
+1,000
| +2% | +$20.4K |
|
2036
Ichor Holdings
ICHR
$587M
| $1.12M | ﹤0.01% |
51,700
+800
| +2% | +$17.3K |
|
|
EBSB
2037
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.11M | ﹤0.01% |
107,200
| – | – |
|
2038
Adtran
ADTN
$818M
| $1.11M | ﹤0.01% |
108,100
| – | – |
|
2039
Agilysys
AGYS
$3.08B
| $1.11M | ﹤0.01% |
45,900
| – | – |
|
2040
Cass Information Systems
CASS
$565M
| $1.11M | ﹤0.01% |
27,452
| – | – |
|
|
PRVB
2041
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.11M | ﹤0.01% |
86,100
| – | – |
|
2042
iHeartMedia
IHRT
$323M
| $1.1M | ﹤0.01% |
135,800
+5,600
| +4% | +$45.5K |
|
2043
Ingles Markets
IMKTA
$1.28B
| $1.1M | ﹤0.01% |
29,000
+500
| +2% | +$19K |
|
2044
DMC Global
BOOM
$139M
| $1.1M | ﹤0.01% |
33,400
| – | – |
|
2045
PC Connection
CNXN
$1.59B
| $1.1M | ﹤0.01% |
26,700
| – | – |
|
2046
Extreme Networks
EXTR
$2.93B
| $1.1M | ﹤0.01% |
272,400
+7,900
| +3% | +$31.8K |
|
2047
Allegiant Air
ALGT
$1.16B
| $1.09M | ﹤0.01% |
9,128
| – | – |
|
2048
TrueCar
TRUE
$187M
| $1.09M | ﹤0.01% |
218,800
+4,600
| +2% | +$23K |
|
|
CLVS
2049
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.09M | ﹤0.01% |
186,600
| – | – |
|
|
EIDX
2050
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.09M | ﹤0.01% |
21,500
| – | – |
|